Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren
Prostate-specific antigen — a true progress in diagnosis and follow-up of prostate cancer
✍ Scribed by E. P. Allhoff; C. A. Olsson
- Publisher
- Springer-Verlag
- Year
- 1993
- Tongue
- English
- Weight
- 74 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Prostate-specific antigen (PSA) is the most accurate serum marker for cancer of the prostate (CAP). However, its sensitivity and specificity are suboptimal, especially at values ranging between 4.1 and 10.0ng/ml (monoclonal), because benign prostatic hypertrophy and hyperplasia (BPH) and CaP frequen
## Abstract __Objective:__ To establish the value of serum prostate‐specific antigen (PSA) and prostatespecific antigen per unit volume of prostate gland (PSAD) in detecting prostate carcinoma (CaP) in a hypothetical screening algorithm, a meta‐analysis of the sensitivities, specificities, predicti
Treatments available for metastatic prostate cancer have failed to demonstrate significant curative potential. Current efforts are now directed towards developments of novel strategies for the treatment of metastatic prostate cancer. Cancer immunotherapeutic strategies utilize patient immune system